Evaluation of Specialty Pharmacy in an Integrated Health-System

Similar documents
Justifying New Oncology Pharmacist Positions

The Un-Special World of Specialty Medications

Walgreens Enterprise Specialty Pharmacy

Panel Discussion: Orals Adherence & Challenges Friday, April 28 th, 2017

Community-Based Point-of-Care Testing: From Innovative Care Model to Common Practice

Cost-Effective Process to Improve Drug Adherence for Medicare 5-Star

9/25/15. Pharmacy Quality Measures: Financial Support. Learning Objectives. Speaker Disclosure. Access to Preferred Networks and Clinical Performance

Role of the Clinical Pharmacist in Primary Care

Navigating The Prior Authorization Approval Process. Kristin Webb, RPCA University at Buffalo

Navigating The Prior Authorization Approval Process

How one pharmacy is bringing specialty drugs to an independent community pharmacy setting

Population Health Management Design: Optimizing the Outcomes for Special Populations 21th Annual ASHP Conference for Pharmacy Leaders

Pre-exposure Prophylaxis for HIV Prevention

Comprehensive support for your patients on MYALEPT

Tips for Evolving Medicaid Pharmacy Benefits Management (PBM) Programs. June 5, 2015

Pharmacy Trends and Management Opportunities. Kerry Bendel, R.Ph. Director of Pharmacy Medica

THE GROWTH OF SPECIALTY PHARMACY

2015 Annual Convention

Magellan Rx. A smarter approach to pharmacy benefits management

Specialty Drugs in Workers Compensation

PHARMACY BENEFITS MANAGER SELECTION FAQ FOR PRODUCERS

IOWA MEDICAID DRUG UTILIZATION REVIEW COMMISSION 100 Army Post Road Des Moines, IA (515) Fax

Digital Technologies: The Solutions to Poor Medication Adherence?

MArch The 2014 Drug Trend Report Highlights

Prescription Benefit Management. Eric Cannon, PharmD, FAMCP

Mary Ann Hodorowicz RDN, MBA, CDE, CEC (Certified

Utilization of Telemedicine to Treat Hepatitis C Virus Infection at a Medication Assisted Treatment Program

Oncology Pharmacy Navigator: A Novel Model for Medication Management

Positive Living Conference

16 th Annual IHA Stakeholders Meeting Session 2C

Moving the Needle: How Are We Doing with Patient Adherence to Drug Therapy?

Pharmacy Partnership to Improve Patient Outcomes

Rethink. Adherence. David D. Pope, PharmD, CDE Editor-in-Chief, CreativePharmacist.com Brands

See Important Reminder at the end of this policy for important regulatory and legal information.

Helpful Resources for people with Diabetes

AzPA Southwestern Clinical Seminar. JW Marriott Starr Pass Blvd., Tucson, AZ

Continuing Education. An integral member of the healthcare team Utilize creative technology Intentional in marketing

Market Distortions from the 340B Drug Pricing Program

ASCO s Quality Training Program

Are Specialty Pharmacy Drugs Worth the Cost? How Companies Can Make Them More Affordable.

Vaccine Starter Kit Program FAQs

Jefferies Healthcare Conference. June 2016

37 th ANNUAL JP MORGAN HEALTHCARE CONFERENCE

Specialty pharmacy is one of the fastest growing areas of

Pharmacotherapy selection system supports shared clinician-patient decision-making in diabetes treatment

SFDPH Responds to Hepatitis C: Strategic Directions for and Beyond

Specialty conditions overview

Adult Immunization Highlights from the 48th National Immunization Conference

Colorectal Cancer- QI process and clinic success: A Case Study at Atascosa Health Center

3/17/2017. Innovative Opportunities for Pharmacists in the Evolving World of Healthcare. Elderly represent about of our emergency medical services:

Innovative Opportunities for Pharmacists in the Evolving World of Healthcare

2016 Pharmacist Re-Licensure Survey Instrument

These reports were prepared pursuant to directive contained in Section 10 of Senate File 2425 which is listed below:

Getting started with Prime

IMPACT OF DRUG REBATES ON YOUR PARTICIPANTS AND YOUR PLAN RISK PROFILE Indiana Health and Wellness Summit

Using Decision Support to Promote Value Based Prescribing

Walgreens (WAG) Analyst: Juan Fabres Fall 2014

Up to $402,000. Insight HIV. Drug Class. 1.2 million people in the United States were living with HIV at the end of 2011 (most recent data).

Telemedicine: Connecting Behavioral Health and Medical Care

How Mail-Servi. Prepared for

ACIP Recommendations for Adult Pneumococcal Immunization: Helping Pharmacists Assess, Recommend, Administer or Refer. Interim Outcomes Report

Medication Therapy Management: Improving Health and Saving Money

Texas Vendor Drug Program Specialty Drug List Process. February 2019

PrEP Implementation in San Francisco. Michael Barajas- Citywide PrEP Navigator San Francisco City Clinic San Francisco Department of Public Health

Oral Chemotherapy Panel

Reducing COPD Exacerbation Readmissions in a Community-Based Teaching Hospital

An Alternative Payment Model Concept for Office-based Treatment of Opioid Use Disorder

Commercial Health Insurance Claims Data. for Studying HIV/AIDS Care. Senior Scientist, Innovus Epidemiology. David D.

The New Role of Cancer Patient Engagement in Value Based Models

IOWA MEDICAID DRUG UTILIZATION REVIEW COMMISSION 100 Army Post Road Des Moines, IA (515) Fax

PBMs: Impact on Cost and Quality of Pharmaceutical Care in the U.S.

Leverage Healthcare Technology Applications to Improve Primary Nonadherence.

Myriad Genetics Corporate Presentation 06/13/2018

Clinical Policy: Valganciclovir (Valcyte) Reference Number: CP.CPA.116 Effective Date: Last Review Date: Line of Business: Commercial

Primary Care Pharmacist Integration and Reimbursement Models

Strengthening our global leadership in treatment of addiction. Morgan Stanley Global Healthcare Conference September 13 th and 14 th 2018

Brantley M. Underwood Pharm.D., MBA PGY1 Community Pharmacy Resident Southwestern Oklahoma State University/Walgreen Co

New patients approved for the Novo Nordisk PAP may only be eligible for insulin vials. For a full list of available products, please visit:

Self-Insurance 2016 Q2 Update. Presented by Marcy Syman, Human Resources Director

Does Variation in the Physical Characteristics of Generic Drugs Affect Patients Experiences?

Global Rheumatoid Arthritis Market: Trends and Opportunities ( )

Ensure access to and compliance with treatment for low-income uninsured Virginia residents living with HIV/AIDS

What CEOs Don t Know about Health System Pharmacy

CARD/MAIL/PRE-APPROVAL/PREFERRED RIDER FOR PRESCRIPTION DRUG [INSURANCE] [Policy]holder: Group Policy No: Effective Date:

Practice Advisory on Drug Coverage Parity across Medical and Pharmacy Benefits

Topic: Sovaldi, sofosbuvir Date of Origin: March 14, Committee Approval Date: August 15, 2014 Next Review Date: March 2015

Addressing Gaps in MS Care. November 6, :00 AM - Noon

Maryland Patient Safety Center s Annual MEDSAFE Conference: Taking Charge of Your Medication Safety Challenges November 3, 2011 The Conference Center

340B Savings Equals Improved Patient Care

Team-Based Decision Support in Diabetes Outcomes and Costs

PREVENTATIVE COMMUNITY PHARMACY DIABETES MANAGEMENT PROGRAMS BROOKE HUDSPETH, PHARMD, CDE, MLDE KROGER DIABETES CARE

The Sustainability of Irish Pharmaceutical Expenditure. Valerie Walshe Ph.D. Economist

Letter to the AMGA Board of Directors... 1 Introduction... 3

April 2o14. The 2013 Drug Trend Report Highlights

Zoster Tdap. Marianne Langlois. Tetanus Diptheria (Td) Hepatitis A Hepatitis A & B combo

2016 Travelers Prescription Drug Plan Blue Cross Blue Shield Plan and United Healthcare Choice Plus Plan

Statement Of. The National Association of Chain Drug Stores. For. U.S. Senate Finance Committee. Hearing on:

How health plans can improve cancer care: from utilization management to delivery reform

Navigating Immuno-Oncology Coverage & Reimbursement Issues

Transcription:

Evaluation of Specialty Pharmacy in an Integrated Health-System Emma Chermely, PharmD, BCACP Alyssa McCann, PharmD, BCACP *The presenters have no conflicts of interest to disclose.

Objectives Introduce the background of specialty pharmacy Evaluate UC Health s Specialty Pharmacy patient population and services Describe the impact a specialty pharmacy can have within a health-system Describe the various role for pharmacy technicians within a specialty pharmacy*. * Technician Learning objective

What is a specialty pharmacy? State-licensed pharmacies that solely or largely provide only medications for serious complex health conditions Connect severely ill patients with disease specific high cost, high touch medications Provide patient care services Support patients through reimbursement challenges Excellent services drive adherence and ensure appropriate medication use The National Association of Specialty Pharmacy. NASP Definitions of Specialty Pharmacy and Specialty Medications (Feb 2016). http:////naspnet.org/wpcontent/uploads/2017/02/nasp-defintions-final-2.16.pdf (accessed 25 Mar 2018). M Goldenhorn, R Smith, PT Rocafort. Understanding the high-touch model. Getting acquainted with specialty pharmacy (Mar 2014). ACPE CE. www.freece.com/freece/cecatalog_details.aspx?id=9a3f14ab-c000-4655-a4a8-c425a2d2b3de (accessed 25 Mar 2018).

What are specialty medications? Medications that require intensive patient management May require special handling, storage and/or administration May be administered orally, subcutaneously, or intravenously May cost up to $750,000 per year Require comprehensive patient care, clinical management, and product support services The National Association of Specialty Pharmacy. NASP Definitions of Specialty Pharmacy and Specialty Medications (Feb 2016). http:////naspnet.org/wpcontent/uploads/2017/02/nasp-defintions-final-2.16.pdf (accessed 25 Mar 2018). M Goldenhorn, R Smith, PT Rocafort. Understanding the high-touch model. Getting acquainted with specialty pharmacy (Mar 2014). ACPE CE. www.freece.com/freece/cecatalog_details.aspx?id=9a3f14ab-c000-4655-a4a8-c425a2d2b3de (accessed 25 Mar 2018).

Impact of Specialty Medications AJPB Top 5 Medications Humira Harvoni Enbrel Rituxan Remicade AJHP Top 5 Medications Humira Lantus Harvoni Enbrel Remicade Spending on specialty medications doubled from 2010 to 2015 Specialty medications contributed 70% to overall growth of drug expenditures Toich L. Top 5 highest-selling drugs of 2016. AJPB (Aug 2017) www.ajbp.com/news/top-5-highestselling-drugs-of-2016 (accessed 25 Mar 2018) Shumock et al. National trends in prescription drug expenditures and projections for 2017. AJHP (May 2017). www.ajhp/org/content/early/2017/05/17/ajhp170164/tab-figures-data (accessed 2018 Mar 25) IMS Institute for Healthcare Informatics. Medicines use and spending in the U.S. A review of 2015 and outlook to 2020 (April 2016). www. imshealth.com/en/thoughtleadership/quintilesims-institute/reports/ medicines-use-and-spending-in-the-us-a-review-of-2015-and-outlook-to-2020 (accessed 2018 Mar 25).

Growth of Specialty Pharmacies Figure 1. Pharmacy Locations with Specialty Pharmacy Accreditation by Corporate Ownership 2015 vs 2016 CAGR: compound annual growth rate Figure 2. Pharmacy Industry Prescription Revenue ($ Billions) Steiber, Dan. Proving value in specialty pharmacy practice: a new yardstick. AJPB (Nov/Dec 2017). www.ajpb.com/journals/ajpb/2017/ajpb_novemberdecember2017/provingvalue-in-specialty-pharmacy-practice-a-new-yardstick (accessed 25 Mar 2018).

Health-System Specialty Models University of Utah Health Care Implemented in 2014 Added 8 technician FTE and 1 pharmacist FTE Goals: 1. Develop centralized prior authorization (PA) process 2. Develop a call center to provide specialty pharmacy services 3. Utilize Electronic Medical Record (EMR) documentation Program Results 137% increase in specialty pharmacy revenue in fiscal year 2015 Average PA approval time of 3 business days Excluded cases involving denials or appeals Rim M. Am J Health Syst Pharm. 2016 Jun 1; 73(11):831-8.

Health-System Specialty Models Vanderbilt Specialty Pharmacy 20 specialty clinics 24 clinical pharmacists and 20 technicians Specialty pharmacists and technicians work from clinic Services are tailored to individual clinic Basic Services Patient counseling Benefits Investigating/Prior Authorization Financial counseling Refill reminder calls 24-hour on-call pharmacist Free shipping Customizable Services Assist in medication selection Lab monitoring Collaborative Practice Agreement Adherence monitoring REMS program management Independent pharmacist clinic visits Bagwell A. J Manag Care Spec Pharm, 2017 Aug; 23(8):815-820.

UC Health Specialty Pharmacy Opened in October 2016 Obtained URAC Accreditation in July 2017 Staffing: 4.5 pharmacists and 2 technicians Service lines covered Solid Organ Transplant Oncology/Hematology Infectious Diseases Gastroenterology Neurology (Multiple Sclerosis) Cardiology

UC Health Specialty Pharmacy Workflow Technician Technician xx Benefits Investigation xx Initiate Prior Authorization xx Approved Document Document Document Uninsured xxmedication Access Referral Z Insured xx Denied High Copay Z Dispense or Transfer Technician Technician Document

UC Health Specialty Pharmacy Workflow Initial Assessment Refill Call Routine Assessment

UC Health Specialty Pharmacy TherigySTM utilized as patient management system Not integrated with Epic Cloud-based product that contains: Patient demographics Therapeutic category Medication Prior authorization information Various activities Medication refills, clinical assessments, clinical interventions

Patients UC Health Specialty Pharmacy Patients 500 450 400 350 300 250 200 150 100 50 0 HCV HIV Hem/Onc Transplant Other Disease State Total 1,189 Patients

Transplant Type Patients by Transplant Type Transplant Service started in October 2015 1 pharmacist Coordinate, fill, and ship all medications for patient Initial and quarterly assessment If > 3 years from transplant, annual assessments Recent study showed improved Proportion of Days Covered (PDC) with specialty pharmacy 88% to 97% (p<0.001) Pancreas Kidney/Pancreas Kidney/Liver Liver Kidney Heart/Kidney Heart 0 20 40 60 80 100 120 140 160 Patients

Human Immunodeficiency Virus (HIV) Service rapidly expanded in January 2018 469 Active Patients 1.5 Clinical Pharmacists 1 Technician

Hepatitis C (HCV) 143 Active Patients 1 Clinical Pharmacist Prior Authorization (PA) turnaround time of 4 business days Month Total Prior Authorizations Prescriptions filled at Specialty January 33 14 February 32 14

Hematology/Oncology 134 Active Patients 16 Hematology 118 Oncology 1 Clinical Pharmacist PA turnaround time of 2 business days Month Total Prior Authorizations Prescriptions filled at Specialty January 28 12 February 27 14

Additional Benefits of an Integrated Specialty Pharmacy Decreased fragmentation Coordinated care within one health-system Utilization of patient s medical record for communication Improved access to medication for patients Increased patient and provider satisfaction

UC Health Medication Access Services Operate with 1 Coordinator and 6 Advocates Highly integrated within UC Health Assist patients and providers with Review and Verification of Insurance Coverage Insurance Benefit Selection Medicare Part D and Medicare Extra Help Diagnosis-specific Foundation Assistance Pharmaceutical-specific Co-pay Assistance Pharmaceutical-specific Patient Assistance Programs 30% of specialty patients utilize these services

Revenue Number of Patients $180,000.00 $160,000.00 $140,000.00 $120,000.00 $100,000.00 $80,000.00 $60,000.00 $40,000.00 $20,000.00 $- Specialty Pharmacy Revenue from Medication Access Services January February March April May June July August September October November December January Month 200 180 160 140 120 100 80 60 40 20 0 Number of Patients Revenue

Cost Avoidance Number of Patients $250,000.00 $200,000.00 Specialty Pharmacy Cost Avoidance from Medication Access Services 45 40 35 $150,000.00 $100,000.00 $50,000.00 30 25 20 15 10 5 $- January February March April May June July August September October November December January Month 0 Cost Avoidance Number of Patients

UC Health Specialty Pharmacy Quality Management Satisfaction surveys conducted quarterly Utilizes a 5 point Likert scale Overall satisfaction of 4.87 and 4.91 for providers and patients Majority of patients received medications via mail Lowest score was affordability of medications 97.3% of patients would recommend UC Health Specialty Pharmacy 91.3% of providers would strongly recommend UC Health Specialty Pharmacy to colleagues

UC Health Specialty Pharmacy Growth *Includes data through 1/31/18

UC Health Specialty Pharmacy Growth *Includes data through 1/31/18

UC Health Specialty Pharmacy Barriers to Care Patient population Limited access to medications Medication cost Pharmacy Benefit Manager (PBM) restrictions Ohio is not an any willing provider state

UC Health Specialty Pharmacy Future Directions Increase staffing Individualized roles for pharmacy technicians Expansion to more specialty clinics Increase access to medications Incorporation of the 4 P s Patient Providers Pharma Payers

Active Learning #1 According to AJPB and AJHP, what was the top selling specialty medication in 2016? A. Imbruvica B. Harvoni C. Prograf D. Humira

Active Learning #2 What are the 4 P s of Specialty Pharmacy? A. Patient, Product, Providers, Pharmacy B. Patient, Product, Pharma, Payers C. Patient, Providers, Pharma, Payers D. Patient, Providers, Pharmacy, Payers

Evaluation of Specialty Pharmacy in an Integrated Health-System Emma Chermely, PharmD, BCACP Alyssa McCann, PharmD, BCACP *The presenters have no conflicts of interest to disclose.